Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Edesa Biotech, Inc.EDSA · Entity 7223 | Director · Chief Executive Officer · 10% owner | October 05, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Edesa Biotech, Inc.
Report date October 05, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 905,993 |
Reported balance
After 2026-10-05 transaction · row 1
1 source rowRow 1 · 2026-10-05 · Grant · Acquired 6,893 · Balance 905,993 F1: Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. |
| Common SharesSEC Table I · non-derivative | IndirectHeld by Pardeep Nijhawan Medicine Professional Corporation | 402,702 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 402,702 F2: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| Common SharesSEC Table I · non-derivative | IndirectHeld by The New Nijhawan Family Trust 2015 | 32,609 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 32,609 F3: Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| Common SharesSEC Table I · non-derivative | IndirectHeld by The Digestive Health Clinic Inc. | 32,013 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 32,013 F2: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| Common SharesSEC Table I · non-derivative | IndirectHeld by 1968160Ontario Inc. | 53,104 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 53,104 F2: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
F2: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3: Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2023 Filed Aug 4, 2023 20:18 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 99,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-23-010166 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 694,112 F1 · price: Reflects a grant of restricted share units ("RSUs"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2022. The number of RSUs was determined by dividing such portion of the cash bonus by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 20:31 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantShare Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001654954-23-009535 · section16.xml · derivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Shares · 120,000 shares Expires 2023-07-20 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the date of grant. Read SEC document |
| July 20, 2023 Filed Jul 24, 2023 20:45 UTC Amendment | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantShare Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001654954-23-009594 · section16.xml · derivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Shares · 120,000 shares Expires 2033-07-20 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the date of grant. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 114,131 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · derivative · entry 9 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 114,131 Underlying: Common Share · 114,131 shares Expires not disclosed F4 · security: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F4 · derivative.exercise_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F4 · derivative.expiration_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 114,131 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · derivative · entry 8 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 114,131 Underlying: Common Shares · 114,131 shares Expires not disclosed F4 · security: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F4 · derivative.exercise_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F4 · derivative.expiration_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 114,131 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · derivative · entry 7 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 114,131 Underlying: Common Share · 114,131 shares Expires not disclosed F3 · security: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F3 · derivative.exercise_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F3 · derivative.expiration_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 114,131 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · derivative · entry 6 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 114,131 Underlying: Common Shares · 114,131 shares Expires not disclosed F3 · security: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F3 · derivative.exercise_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F3 · derivative.expiration_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 228,262 | $1.13 | $256,794.75 |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 228,262 F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 228,262 | $1.13 | $256,794.75 |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,356,914 F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 13:38 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 20,000 | $1.60 | $32,078.00 |
DisclosureSEC source: 0001654954-22-009259 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,812 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.52 to $1.6622. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 27, 2022 Filed May 31, 2022 09:00 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 5,000 | $1.92 | $9,599.00 |
DisclosureSEC source: 0001654954-22-007684 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,812 Read SEC document |
| May 24, 2022 Filed May 25, 2022 12:13 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $1.80 | $3,599.60 |
DisclosureSEC source: 0001654954-22-007509 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,812 Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 10:56 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $2.99 | $5,971.60 |
DisclosureSEC source: 0001654954-22-004413 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,812 Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 10:52 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $3.05 | $6,098.20 |
DisclosureSEC source: 0001654954-22-004245 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,812 Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 12:47 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $3.02 | $6,033.60 |
DisclosureSEC source: 0001654954-22-004118 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,812 Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 10:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $3.85 | $7,699.20 |
DisclosureSEC source: 0001654954-22-003483 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,812 Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 11:26 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,603 | $3.26 | $5,232.19 |
DisclosureSEC source: 0001654954-22-003409 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,812 Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 11:26 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 397 | $3.25 | $1,290.17 |
DisclosureSEC source: 0001654954-22-003409 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,209 Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 11:17 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $2.80 | $5,598.00 |
DisclosureSEC source: 0001654954-22-003224 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,812 Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 13:59 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 5,000 | $3.06 | $15,294.50 |
DisclosureSEC source: 0001654954-22-003095 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,812 Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 13:59 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $3.18 | $6,357.60 |
DisclosureSEC source: 0001654954-22-003095 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,812 Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 11:10 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,500 | $3.05 | $4,569.60 |
DisclosureSEC source: 0001654954-22-002850 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548,812 Read SEC document |
| February 28, 2022 Filed Mar 8, 2022 00:37 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantStock Option (right to buy) · Derivative | 49,000 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001654954-22-002646 · section16.xml · derivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,000 Underlying: Common Shares · 49,000 shares Expires 2032-02-28 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 21:04 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $5.45 | $0.00 |
DisclosureSEC source: 0001654954-21-004637 · section16.xml · derivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Shares · 120,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 11:44 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 3,000 | $5.25 | $15,750.00 |
DisclosureSEC source: 0001654954-21-003334 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,312 Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 14:43 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 5,000 | $5.16 | $25,800.00 |
DisclosureSEC source: 0001654954-21-003274 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,312 Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 10:00 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | OtherCommon share warrants (Right to buy) · Derivative | 4,628 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011925 · section16.xml · derivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 0 Underlying: Common shares · 4,628 shares Expires 2020-11-08 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 10:00 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | OtherCommon Shares | 4,628 | $4.00 | $18,512.00 |
DisclosureSEC source: 0001654954-20-011925 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,128,652 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:54 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $7.44 | $0.00 |
DisclosureSEC source: 0001654954-20-011144 · section16.xml · derivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common shares · 60,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: This option vests monthly in equal proportions over 36 months beginning on the Grant Date. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 09:23 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | OtherCommon Shares | 371,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-20-010224 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by 1968160 Ontario Inc. Disclosed balance after: 371,727 F2 · price: Pardeep Nijhawan acquired 100% of the capital stock of 1968160 Ontario Inc. which holds 371,727 common shares of the issuer, pursuant to the foreign equivalent of a domestic relations order. F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| May 26, 2020 Filed May 28, 2020 12:19 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 3,000 | $2.98 | $8,939.10 |
DisclosureSEC source: 0001654954-20-006029 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation (1) Disclosed balance after: 2,124,024 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 29, 2020 Filed Mar 29, 2021 13:02 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $5.23 | $10,460.00 |
DisclosureSEC source: 0001654954-21-003384 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,312 Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.90 | $1,897.50 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,121,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.83 | $1,828.00 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 4 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,120,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.90 | $1,897.80 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 3 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,119,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.86 | $1,859.90 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,118,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.89 | $1,889.90 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,117,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 4,628 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · derivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 4,628 Underlying: Common Shares · 4,628 shares Expires 2020-11-08 F4 · security: Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020. F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 6,942 | Not disclosed Strike: $4.80 | Not disclosed |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · derivative · entry 4 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 6,942 Underlying: Common Shares · 6,942 shares Expires 2023-07-08 F3 · security: Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023. F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 9,255 | $4.11 | $38,038.05 |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,116,024 F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 22:51 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantStock Option (right to buy) · Derivative | 91 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001777962-19-000003 · primary_doc.xml · derivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,620 Underlying: Common Shares · 91 shares Expires 2028-12-28 F4 · derivative.exercise_price: In Canadian currency. F3 · shares: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. F5 · shares: This option was issued in replacement of an option to purchase shares of Edesa. F7 · derivative.exercise_date: This option vests and becomes exercisable 1/3 on December 28, 2019, and monthly thereafter through December 28, 2021. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 22:51 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantStock Option (right to buy) · Derivative | 2,667 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001777962-19-000003 · primary_doc.xml · derivative · entry 4 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,490 Underlying: Common Shares · 2,667 shares Expires 2027-09-26 F4 · derivative.exercise_price: In Canadian currency. F3 · shares: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. F5 · shares: This option was issued in replacement of an option to purchase shares of Edesa. F6 · derivative.exercise_date: This option vests and becomes exercisable 1/3 on September 26, 2018, and monthly thereafter through September 26, 2020. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 22:51 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 12,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001777962-19-000003 · primary_doc.xml · nonDerivative · entry 3 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by The Digestive Health Clinic Inc. Disclosed balance after: 224,094 F1 · shares: Represents additional common shares or options to purchase common shares, as applicable, of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa"), and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders. F2 · shares: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. F3 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 22:51 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 118,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001777962-19-000003 · primary_doc.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation. Disclosed balance after: 2,106,769 F1 · shares: Represents additional common shares or options to purchase common shares, as applicable, of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa"), and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders. F2 · shares: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. F3 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 22:51 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 30,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001777962-19-000003 · primary_doc.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,312 F1 · shares: Represents additional common shares or options to purchase common shares, as applicable, of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa"), and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders. F2 · shares: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. Read SEC document |
| June 07, 2019 Filed Jun 12, 2019 00:58 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantStock Option (right to buy) · Derivative | 1,529 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001777962-19-000002 · primary_doc.xml · derivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,529 Underlying: Common Shares · 1,529 shares Expires 2028-12-28 F4 · derivative.exercise_price: In Canadian currency. F2 · shares: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. F5 · shares: This option was issued in replacement of an option to purchase shares of Edesa. F7 · derivative.exercise_date: This option vests and becomes exercisable 1/3 on 12/28/19, and monthly thereafter through 12/28/21. Read SEC document |
| June 07, 2019 Filed Jun 12, 2019 00:58 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantStock Option (right to buy) · Derivative | 44,823 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001777962-19-000002 · primary_doc.xml · derivative · entry 4 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,823 Underlying: Common Shares · 44,823 shares Expires 2027-09-26 F4 · derivative.exercise_price: In Canadian currency. F2 · shares: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. F5 · shares: This option was issued in replacement of an option to purchase shares of Edesa. F6 · derivative.exercise_date: This option vests and becomes exercisable 1/3 on 9/26/18, and monthly thereafter through 9/26/20. Read SEC document |
| June 07, 2019 Filed Jun 12, 2019 00:58 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 211,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001777962-19-000002 · primary_doc.xml · nonDerivative · entry 3 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by The Digestive Health Clinic Inc. Disclosed balance after: 211,506 F1 · shares: Represents common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.)(the "Issuer") issued in the share exchange transaction that was completed on June 7, 2019, pursuant to that certain Share Exchange Agreement, dated March 7, 2019, by and among the Issuer, Edesa Biotech Inc. ("Edesa") and the shareholders of Edesa Biotech Inc. F2 · shares: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. F3 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| June 07, 2019 Filed Jun 12, 2019 00:58 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 1,988,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001777962-19-000002 · primary_doc.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 1,988,424 F1 · shares: Represents common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.)(the "Issuer") issued in the share exchange transaction that was completed on June 7, 2019, pursuant to that certain Share Exchange Agreement, dated March 7, 2019, by and among the Issuer, Edesa Biotech Inc. ("Edesa") and the shareholders of Edesa Biotech Inc. F2 · shares: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. F3 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| June 07, 2019 Filed Jun 12, 2019 00:58 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 507,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001777962-19-000002 · primary_doc.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,129 F1 · shares: Represents common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.)(the "Issuer") issued in the share exchange transaction that was completed on June 7, 2019, pursuant to that certain Share Exchange Agreement, dated March 7, 2019, by and among the Issuer, Edesa Biotech Inc. ("Edesa") and the shareholders of Edesa Biotech Inc. F2 · shares: All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.